MediXall Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 04:39 pm
Share
MediXall Group, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.020766 million compared to USD 0.003773 million a year ago. Net loss was USD 1.08 million compared to USD 1.39 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
For the nine months, sales was USD 0.039025 million compared to USD 0.173686 million a year ago. Net loss was USD 5.05 million compared to USD 4.38 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.04 a year ago. Diluted loss per share from continuing operations was USD 0.05 compared to USD 0.04 a year ago.
MediXall Group, Inc. is a technology company. The Company is engaged in delivering products and services to help consumers learn, decide, and pay for healthcare in ways that complement relationships with trusted doctors. With Health Karma, it has created a membership model that provides consumers with convenience and access to whenever and wherever, while driving down overall healthcare costs. It provides its members access to licensed healthcare providers across a spectrum of care through copay virtual primary, urgent, and behavioral care, as well as significant discounts to prescriptions, dental care, eye care, hearing and medical equipment. For employers, Its Health Karma membership offers a comprehensive way for them to offer supplemental health benefits to all of their employees, including part-time and gig workers. The Companyâs subsidiaries include Medixaid, Inc., MediXall.com, Inc. and Health Karma, Inc.
MEDIXALL GROUP, INC. 
